Inactive Instrument

Franchise Global Health Inc. Stock

MERC.P

CA58937M1077

Chart Franchise Global Health Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Franchise Global Health Inc.

Flora Growth Closes Acquisition of Franchise Global Health, Cementing Foothold in Germany and EU	22-12-28	MT
Flora Growth Corp. completed the acquisition of Franchise Global Health Inc. from a group of shareholders.	22-12-22	CI
Franchise Global Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-29	CI
Franchise Global Health Agrees to Be Bought by Flora Growth	22-10-24	MT
Flora Growth Corp. entered into a definitive agreement to acquire Franchise Global Health Inc. from a group of shareholders for CAD 32.2 million.	22-10-23	CI
Franchise Global Health Reports Q1 Loss, Higher Revenue	22-05-27	MT
Franchise Global to Acquire German Pharmaceutical and Medical Cannabis Products Distributor	22-05-16	MT
Franchise Global Health Inc. agreed to acquire Targeted Microbody Therapeutics Ug (haftungsbeschränkt).	22-05-15	CI
Franchise Global Health Inc. Auditor Raises 'Going Concern' Doubt	22-05-01	CI
Franchise Global Health Inc. Appoints Dany Vaiman as Chief Financial Officer	22-03-25	CI
Franchise Global Health Inc. Announces the Resignation of Hani Zabaneh as Director	22-03-25	CI
Franchise Global Health Inc. Announces Executive Changes	22-03-25	CI
Franchise Global Health Inc. Announces Management Changes	22-03-25	CI
Franchise Cannabis Corp. completed the acquisition of Mercury Acquisitions Corp. (TSXV:MERC.P).	22-03-24	CI
Franchise Global Health Inc. Auditor Raises 'Going Concern' Doubt	22-03-09	CI

More news

Press releases Franchise Global Health Inc.

Franchise Global Reports Third Quarter 2022 Financial Results; Revenues Increased by $11.7 Million YoY to $11.9 Million	22-11-29	AQ
Franchise Global Health Inc. Announces 73.8% Shareholder Backing for Flora Growth's Acquisition of the Company	22-11-10	AQ
Franchise Global Health Executes Definitive Agreement with Flora Growth for the Acquisition of Franchise Global Health	22-10-24	AQ
Franchise Global Reports Second Quarter 2022 Financial Results; Revenues Increased by $13.1 Million YoY to $13.5 Million	22-08-26	AQ
Franchise Global Health Inc. Announces Timing of Release of Second Quarter Results and Conference Call	22-08-19	AQ

More press releases

News in other languages on Franchise Global Health Inc.

Europas erste legale, registrierte Cannabis-Saatgutbank

22-04-28

More news

Managers and Directors - Franchise Global Health Inc.

Managers	Title	Age	Since
Clifford Starke CEO	Chief Executive Officer	41	19-11-24
Jan Anderson PRN	Corporate Officer/Principal	42	-
Nasir Bhatti PRN	Corporate Officer/Principal	41	-

Members of the board	Title	Age	Since
Robert Cross BRD	Director/Board Member	65	-
Peter Simeon BRD	Director/Board Member	47	19-11-24
Farhan Lalani BRD	Director/Board Member	44	-

More insiders

Franchise Global Health Inc. is a Canada-based medical cannabis company. The Company is focused on medical cannabis operations in genetics, cultivation, and pharma distribution. It operates as a multi-national operator in the medical cannabis and pharmaceutical industries with operations, assets, strategic partnerships and investments in Germany, St. Vincent & the Grenadines, Portugal and Denmark. The Company's geographical segments include Germany and Denmark. Its subsidiaries include Harmony Health One Inc., ACA Muller, Sativa Verwaltungs GmbH, Sativa Verwaltungs GmbH and Co. KG, CBD Med Therapeutics Inc., Fayber Technologies Canada Inc., Catalunia SAS, Green CannaHealth SAS, Klokken Aarhus Inc., Rangers Pharmaceuticals A/S, 1200325 B.C. LTD., Phatebo, and FCC.

Sector

More about the company